progression-free-survival

Documents about progression-free-survival

• Advanced Pancreatic Cancer#912791ClinicalTrials.gov
• An individualized nomogram for predicting progression-free survival in systemic anaplastic large cell lymphoma: a multicenter, retrospective, and internally validated study.#453146PubMed
• Determination of Immune Phenotype in Glioblastoma Patients#833548ClinicalTrials.gov
• International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma#872547ClinicalTrials.gov
• Mesenteric Lymph Node Metastasis and Nutritional Status After Bowel Resection for Ovarian Cancer#839444ClinicalTrials.gov
• Predicting progression-free survival in glioblastoma with neuroimaging and machine learning.#244370NCBI PubMed Central
• Adjuvant Treatment of Apatinib in Nasopharyngeal Carcinoma#837285ClinicalTrials.gov
• Cell-free DNA dynamics and progression-free survival in metastatic gastroesophageal adenocarcinoma: insights from the REGIRI-PRODIGE 58 ancillary study#370788HAL (France)
• PFS and OS of Patients With Advanced Neuroendocrine Cancer (NEN) After Systemic Treatment#979914ClinicalTrials.gov
• Baseline D-dimer as a predictor of immune checkpoint inhibitor efficacy in cancer#4693Europe PMC
• The association of hypoxia-inducible factor-1 alpha expression, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio with three-year progression-free survival in locally advanced colorectal cancer patients#481477ARPHA OAI-PMH Endpoint
• Long-term radiological progression after resection of dysembryoplastic neuroepithelial tumors: patterns and prognostic factors#5512Europe PMC
• Treatment Response and Prognosis in Glioma Patients: Q Cell and Its Biological Characteristics#881009ClinicalTrials.gov
• Predicting progression-free survival in glioblastoma: influence of the perilesional oedema and white-matter disconnectome#422515Europe PMC
• Metformin for the Treatment of mCRC Patients Undergoing FOLFIRI Plus Target Therapy#429726ClinicalTrials.gov
• Progression-free Survival After MWA Plus Durvalumab and Tremelimumab for Unresectable Locally Advanced Pancreatic Cancer#858236ClinicalTrials.gov
• Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma#208453ClinicalTrials.gov
• Dasatinib in Combination With Melphalan and Prednisone to Treat Relapsed and Refractory Multiple Myeloma Patients#810571ClinicalTrials.gov
• Real-world EHR-derived progression-free survival across successive lines of therapy informs metastatic breast cancer risk stratification#133208bioRxiv / medRxiv
• Association Between Drug-related Cutaneous Adverse Events and Progression Free Survival in Patients Treated with Enfortumab Vedotin#905202ClinicalTrials.gov
• HF-SRT vs. HS-WBRT in Treating Patients With Brain Oligometastases#851369ClinicalTrials.gov
• Relationship between overall survival and progression-free survival with 18 F-FDG PET/CT metabolic parameters in metastatic breast cancer patients treated with CDK 4/6 inhibitors#310720AVESIS
• Predictive value of EGFR amplification and EGFRvIII mutation in EGFR-targeted therapy for recurrent glioblastoma: a systematic review#304159Europe PMC
• Salvage surgery following primary treatment in recurrent vestibular schwannoma: surgical outcomes and progression-free survival- a meta-analysis.#244227NCBI PubMed Central
• Study to Evaluate Progression Free Survival in Cancer Patients With Advanced Colorectal Carcinoma With AMT2003#861485ClinicalTrials.gov
• A functional prognostic model predicts progression-free survival in patients with relapsed chronic lymphocytic leukemia treated with ibrutinib + venetoclax.#1001057NCBI PubMed Central
• Real-world EHR-derived progression-free survival across successive lines of therapy informs metastatic breast cancer risk stratification#135527Unpaywall
• Supplementary Material for: Progression-free survival effect sizes in randomized controlled trials of targeted cancer therapies with positive outcomes#333580Figshare
• Dara-PD in the Treatment of Patients With First Relapse of Multiple Myeloma#857959ClinicalTrials.gov
• Study of Modified FOLFIRINOX in Advanced Pancreatic Cancer#898516ClinicalTrials.gov
• Study of MK 2206 in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma#978953ClinicalTrials.gov
• A Study of PC Sequential Pemetrexed Single Drug Maintenance Treatment for NSCLC and Related Predictive Biomarkers#807301ClinicalTrials.gov
• <i>CIS Predicts PFS in mccRCC</i>#264753Figshare
• Baseline and early 18F-FDG PET/CT evaluations as predictors of progression-free survival in metastatic breast cancer patients treated with targeted anti-CDK therapy#676820HAL (France)
• A Neurocognitive Study in Patients With Brain Oligometastases Receiving Hypofractionated SRT#901531ClinicalTrials.gov
• Vitamin C and Tyrosine Kinase Inhibitor in Lung Cancer Patients With Epidermal Growth Factor Receptor Mutations#898118ClinicalTrials.gov
• TRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma#843100ClinicalTrials.gov
• IPO-NEC Trial:Study on the Efficacy and Safety Using Sequential IP Therapy and Oct Lar in the Treatment of Advanced GI NEC#834482ClinicalTrials.gov
• Erbitux in Combination With Xeloda and Cisplatin in Advanced Esophago-gastric Cancer#876649ClinicalTrials.gov
• Role of Total Neoadjuvant Therapy in Non-Metastatic Mid and Low Rectal Cancer. Experience of the Medical Oncology Department at the Pierre and Marie Curie Center, Algiers#427369HAL (France)
• Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON).#847200ClinicalTrials.gov
• Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology#827252ClinicalTrials.gov
• Prognostic impact of time to first recurrence in low-grade serous ovarian carcinoma: A multicentric retrospective study from the French TMRG network#374382HAL (France)
• The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)#902826ClinicalTrials.gov
• Open radiofrequency ablation as upfront treatment for locally advanced pancreatic cancer: Requiem from a randomized controlled trial#298593IRIS
• Comparative Study of Chemoradiation and Sequential Chemoradiation About Lung Adenocarcinoma Patients With Postoperative in pN2#862935ClinicalTrials.gov
• A Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free Survival#898710ClinicalTrials.gov
• Phase II, Open Label, Non-randomized, Trial of BKM120 for Metastatic or Locally Advanced Cervical Cancer#844161ClinicalTrials.gov
• Study of Selumetinib (AZD6244)(ARRY-142886) in Combination With Irinotecan in Previously Treated Patients With Colorec#896443ClinicalTrials.gov
• Osimertinib or Docetaxel-bevacizumab as Third-line Treatment in EGFR T790M Mutated Non-Small Cell Lung Cancer#889967ClinicalTrials.gov